Core Viewpoint - A securities class action lawsuit has been filed against Ardent Health, Inc. following significant adverse accounting adjustments of approximately $90 million, leading to a stock price decline of over 33% [1][7] Group 1: Lawsuit Details - The lawsuit seeks to represent investors who acquired Ardent securities between July 18, 2024, and November 12, 2025 [1] - The case is titled Postiwala v. Ardent Health, Inc. et al., and focuses on Ardent's disclosures regarding accounts receivable collectability and reserves [3] - The lead plaintiff deadline for the lawsuit is set for March 9, 2026 [2] Group 2: Allegations and Financial Impact - Allegations include that Ardent's leadership was aware of material weaknesses in internal controls related to revenue recognition and failed to disclose these issues [2] - The company reported a revenue decrease of $42.6 million due to a change in accounting estimates and a new revenue accounting system that recognizes reserves earlier [6] - An increase in total operating expenses as a percentage of total revenue was driven by a $47.2 million increase in professional liability reserves [6] Group 3: Market Reaction - Following the financial disclosures on November 12, 2025, Ardent's stock price fell by $4.75, representing a 33% decline [7] - The significant revenue reduction and reserve increase raised questions about whether these issues should have been disclosed to investors earlier [8]
Ardent Health (ARDT) Facing Securities Class Action Amid Receivables and Reserves Issues Driving 33% Plunge – Hagens Berman